Search
satralizumab-mwge (Enspryng])
Indications:
- treatment of neuromyelitis optica spectrum disorder (MOSD)in adults who are aquaporin-4 (AQP4) antibody positive
Contraindications:
- hepatitis B infection
- active or latent tuberculosis
Dosage:
Prefilled Syringe: 120 mg/mL Adverse effedcts:
- may cause life-threatening infections
Mechanism of action:
- monoclonal antibody inhibiting IL-6
Interactions
drug adverse effects of pharmaceutical monoclonal antibodies
General
pharmaceutical monoclonal antibody
neurologic agent
References
- https://www.enspryng.com/about.html